AIMS/HYPOTHESIS: Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women. In this multicentre prospective study, we determined levels of these and related factors in pregnant women with type 1 diabetes, a condition associated with a fourfold increase in pre-eclampsia. METHODS: Maternal serum sFlt1, endoglin, placental growth factor (PlGF) and pigment epithelial derived factor were measured in 151 type 1 diabetic and 24 healthy non-diabetic women at each trimester and at term. RESULTS: Approximately 22% of the diabetic women developed pre-eclampsia, primarily after their third trimester visit. In women with pre-eclampsia (diabetic pre-eclampsia, n = 26) vs those without hypertensive complications (diabetic normotensive, n = 95), significant changes in angiogenic factors were observed, predominantly in the early third trimester and prior to clinical manifestation of pre-eclampsia. Serum sFlt1 levels were increased approximately twofold in type 1 diabetic pre-eclampsia vs type 1 diabetic normotensive women at the third trimester visit (p < 0.05) and the normal rise of PlGF during pregnancy was blunted (p < 0.05). Among type 1 diabetic women, third trimester sFlt1 and PlGF were inversely related (r(2) = 42%, p < 0.0001). Endoglin levels were increased significantly in the diabetic group as a whole vs the non-diabetic group (p < 0.0001). CONCLUSIONS/ INTERPRETATION: Higher sFlt1 levels, a blunted PlGF rise and an elevated sFlt1/PlGF ratio are predictive of pre-eclampsia in pregnant women with type 1 diabetes. Elevated endoglin levels in women with type 1 diabetes may confer a predisposition to pre-eclampsia and may contribute to the high incidence of pre-eclampsia in this patient group.
AIMS/HYPOTHESIS: Elevated anti-angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt1), a soluble form of vascular endothelial growth factor receptor, and endoglin, a co-receptor for TGFbeta1, confer high risk of pre-eclampsia in healthy pregnant women. In this multicentre prospective study, we determined levels of these and related factors in pregnant women with type 1 diabetes, a condition associated with a fourfold increase in pre-eclampsia. METHODS: Maternal serum sFlt1, endoglin, placental growth factor (PlGF) and pigment epithelial derived factor were measured in 151 type 1 diabetic and 24 healthy non-diabeticwomen at each trimester and at term. RESULTS: Approximately 22% of the diabeticwomen developed pre-eclampsia, primarily after their third trimester visit. In women with pre-eclampsia (diabetic pre-eclampsia, n = 26) vs those without hypertensive complications (diabetic normotensive, n = 95), significant changes in angiogenic factors were observed, predominantly in the early third trimester and prior to clinical manifestation of pre-eclampsia. Serum sFlt1 levels were increased approximately twofold in type 1 diabetic pre-eclampsia vs type 1 diabetic normotensive women at the third trimester visit (p < 0.05) and the normal rise of PlGF during pregnancy was blunted (p < 0.05). Among type 1 diabeticwomen, third trimester sFlt1 and PlGF were inversely related (r(2) = 42%, p < 0.0001). Endoglin levels were increased significantly in the diabetic group as a whole vs the non-diabetic group (p < 0.0001). CONCLUSIONS/ INTERPRETATION: Higher sFlt1 levels, a blunted PlGF rise and an elevated sFlt1/PlGF ratio are predictive of pre-eclampsia in pregnant women with type 1 diabetes. Elevated endoglin levels in women with type 1 diabetes may confer a predisposition to pre-eclampsia and may contribute to the high incidence of pre-eclampsia in this patient group.
Authors: Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi Journal: Nat Med Date: 2006-06-04 Impact factor: 53.440
Authors: Nan Hee Kim; Jeong Heon Oh; Ji A Seo; Kye Won Lee; Sin Gon Kim; Kyung Mook Choi; Sei Hyun Baik; Dong Seop Choi; Young Sun Kang; Sang Youb Han; Kum Hyun Han; Yi Hwa Ji; Dae Ryong Cha Journal: Kidney Int Date: 2005-01 Impact factor: 10.612
Authors: Myles Wolf; Anand Shah; Chun Lam; Abelardo Martinez; Karen V Smirnakis; Franklin H Epstein; Robert N Taylor; Jeffrey L Ecker; S Ananth Karumanchi; Ravi Thadhani Journal: Am J Obstet Gynecol Date: 2005-07 Impact factor: 8.661
Authors: Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi Journal: J Clin Invest Date: 2003-03 Impact factor: 14.808
Authors: A J Jenkins; S X Zhang; K G Rowley; C S Karschimkus; C L Nelson; J S Chung; D N O'Neal; A S Januszewski; K D Croft; T A Mori; G Dragicevic; C A Harper; J D Best; T J Lyons; J-X Ma Journal: Diabet Med Date: 2007-10-29 Impact factor: 4.359
Authors: Arpita Basu; Petar Alaupovic; Mingyuan Wu; Alicia J Jenkins; Yongxin Yu; Alison J Nankervis; Kristian F Hanssen; Hanne Scholz; Tore Henriksen; Bjørg Lorentzen; Torun Clausen; Satish K Garg; M Kathryn Menard; Samar M Hammad; James A Scardo; John R Stanley; Azar Dashti; Christopher E Aston; Timothy J Lyons Journal: J Clin Endocrinol Metab Date: 2012-03-21 Impact factor: 5.958
Authors: Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Samuel M Lockhart; Mei Du; Alicia J Jenkins; Alison Nankervis; Kristian F Hanssen; Tore Henriksen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Christopher C Patterson; Timothy J Lyons Journal: Diabetologia Date: 2017-09-05 Impact factor: 10.122
Authors: Tammy Nguyen; Saunders Lin; Ahmed F Pantho; Belinda M Kohl-Thomas; Madhava R Beeram; David C Zawieja; Thomas J Kuehl; M Nasir Uddin Journal: Mol Cell Biochem Date: 2015-04-12 Impact factor: 3.396
Authors: Arpita Basu; Jeremy Y Yu; Alicia J Jenkins; Alison J Nankervis; Kristian F Hanssen; Tore Henriksen; Bjørg Lorentzen; Satish K Garg; M Kathryn Menard; Samar M Hammad; James A Scardo; Christopher E Aston; Timothy J Lyons Journal: Nutr Res Date: 2015-04-11 Impact factor: 3.315
Authors: Y Yu; K F Hanssen; V Kalyanaraman; A Chirindel; A J Jenkins; A J Nankervis; P A Torjesen; H Scholz; T Henriksen; B Lorentzen; S K Garg; M K Menard; S M Hammad; J A Scardo; J R Stanley; M Wu; A Basu; C E Aston; T J Lyons Journal: BJOG Date: 2012-08-20 Impact factor: 6.531